General discussion and future perspectives 225 22. Savenije MHF, Maspero M, Sikkes GG, van der Voort van Zyp JRN, T. J. Kotte AN, Bol GH, et al. Clinical implementation of MRI-based organs-at-risk autosegmentation with convolutional networks for prostate radiotherapy. Radiat Oncol 2020;15:104. 23. Eppenhof KAJ, Maspero M, Savenije MHF, de Boer JCJ, van der Voort van Zyp JRN, Raaymakers BW, et al. Fast contour propagation for MR-guided prostate radiotherapy using convolutional neural networks. Med Phys 2020;47:1238–48. 24. de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, et al. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. Front Oncol 2020;10:1328. 25. Bosma LS, Zachiu C, Ries M, Denis de Senneville B, Raaymakers BW. Quantitative investigation of dose accumulation errors from intrafraction motion in MRgRT for prostate cancer. Phys Med Biol 2021;66:65002. 26. Raaijmakers AJE, Raaymakers BW, Lagendijk JJW. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: dose increase at tissue--air interfaces in a lateral magnetic field due to returning electrons. Phys Med & Biol 2005;50:1363. 27. Hissoiny S, Raaijmakers AJE, Ozell B, Després P, Raaymakers BW. Fast dose calculation in magnetic fields with GPUMCD. Phys Med Biol 2011;56:5119–29. 28. Snyder JE, St-Aubin J, Yaddanapudi S, Marshall S, Strand S, Kruger S, et al. Reducing MRI-guided radiotherapy planning and delivery times via efficient leaf sequencing and segment shape optimisation algorithms. Phys Med Biol 2022;67:55005. 29. Kontaxis C, Bol GH, Lagendijk JJW, Raaymakers BW. DeepDose: towards a fast dose calculation engine for radiation therapy using deep learning. Phys Med Biol 2020;65:075013. 30. de Muinck Keizer DM, van der Voort van Zyp JRN, de Groot-van Breugel EN, Raaymakers BW, et al. On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy. Phys Imaging Radiat Oncol 2021;19:90– 5. 31. Ballhausen H, Li M, Hegemann NS, Ganswindt U, Belka C. Intrafraction motion of the prostate is a random walk. Phys Med & Biol 2014;60:549. 32. Kontaxis C, de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, den Hartogh MD, van der Voort van Zyp JRN, et al. Dosimetric impact of soft-tissue based intrafraction motion from 3D cine-MR in MR-guided prostate radiotherapy 2019. 33. Menten MJ, Mohajer JK, Nilawar R, Bertholet J, Dunlop A, Pathmanathan AU, et al. Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging. Radiother Oncol 2020;145:88–94. 34. Alongi F, Cozzi L, Arcangeli S, Iftode C, Comito T, Villa E, et al. Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. Radiat Oncol 2013;8:171. 35. D’Agostino G, Franzese C, De Rose F, Franceschini D, Comito T, Villa E, et al. High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. Clin Oncol 2016;28:e173–8. 36. Zilli T, Franzese C, Bottero M, Giaj-Levra N, Förster R, Zwahlen D, et al. Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial. Radiother Oncol 2019;139:83–6. 37. Kontaxis C, Woodhead PL, Bol GH, Lagendijk JJW, Raaymakers BW. Proof-of-concept delivery of intensity modulated arc therapy on the Elekta Unity 1.5 T MR-linac. Phys Med & Biol 2020. 38. Uijtewaal P, Borman P, Woodhead P, Kontaxis C, Hackett S, Verhoeff J, et al. OC-0616 First VMAT delivery with MLC-tracking for single and multi fraction lung SBRT on a Unity MR-linac. Radiother Oncol 2021;161:S479–80. 39. Kerkmeijer LGW, Groen VH, Pos FJ, Haustermans K, Monninkhof EM, Smeenk RJ, et al. Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localised Prostate Cancer: Results From the FLAME Randomized Phase III Trial. J Clin Oncol 2021:JCO2002873. 40. Draulans C, van der Heide UA, Haustermans K, Pos FJ, van Zyp J van der V, De Boer H, et al. Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer. Radiother Oncol 2020;147:92–8. 41. Zilli T, Scorsetti M, Zwahlen D, Franzese C, Förster R, Giaj-Levra N, et al. ONE SHOT-single shot radiotherapy for localised prostate cancer: study protocol of a single arm, multicenter phase I/II trial. Radiat Oncol 2018;13:1–8. 42. Skouboe S, Ravkilde T, Bertholet J, Hansen R, Worm ES, Muurholm CG, et al. First clinical real-time motionincluding tumor dose reconstruction during radiotherapy delivery. Radiother Oncol 2019;139:66– 71. 11
RkJQdWJsaXNoZXIy MTk4NDMw